Compare LAES & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAES | SOPH |
|---|---|---|
| Founded | 2022 | 2011 |
| Country | Switzerland | Switzerland |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 366.0M | 342.6M |
| IPO Year | N/A | 2021 |
| Metric | LAES | SOPH |
|---|---|---|
| Price | $4.87 | $4.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $6.00 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 16.1M | 101.1K |
| Earning Date | 12-11-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $10,978,000.00 | ★ $73,297,000.00 |
| Revenue This Year | N/A | $16.60 |
| Revenue Next Year | N/A | $19.09 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.66 |
| 52 Week Low | $0.35 | $2.58 |
| 52 Week High | $11.00 | $5.30 |
| Indicator | LAES | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 50.50 | 56.65 |
| Support Level | $4.16 | $4.54 |
| Resistance Level | $5.10 | $5.29 |
| Average True Range (ATR) | 0.44 | 0.32 |
| MACD | 0.09 | 0.04 |
| Stochastic Oscillator | 87.79 | 72.60 |
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.